These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33487303)

  • 21. Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate.
    Nguyen NK; Deehan EC; Zhang Z; Jin M; Baskota N; Perez-Muñoz ME; Cole J; Tuncil YE; Seethaler B; Wang T; Laville M; Delzenne NM; Bischoff SC; Hamaker BR; Martínez I; Knights D; Bakal JA; Prado CM; Walter J
    Microbiome; 2020 Aug; 8(1):118. PubMed ID: 32814582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiota-derived imidazole propionate inhibits type 2 diabetic skin wound healing by targeting SPNS2-mediated S1P transport.
    Zheng S; Wang H; Han J; Dai X; Lv Y; Sun T; Liu H
    iScience; 2023 Nov; 26(11):108092. PubMed ID: 37876799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial.
    Palacios T; Vitetta L; Coulson S; Madigan CD; Denyer GS; Caterson ID
    Trials; 2017 Jan; 18(1):7. PubMed ID: 28069054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imidazole Propionate is Increased in Diabetes and Associated with Stool Consistency.
    Wu B; Tan L; Wang W; Feng X; Yan D
    Diabetes Metab Syndr Obes; 2022; 15():1715-1724. PubMed ID: 35698651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial.
    Bo S; Ponzo V; Evangelista A; Ciccone G; Goitre I; Saba F; Procopio M; Cassader M; Gambino R
    Acta Diabetol; 2017 May; 54(5):499-507. PubMed ID: 28238190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
    Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
    Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes.
    van Bommel EJM; Herrema H; Davids M; Kramer MHH; Nieuwdorp M; van Raalte DH
    Diabetes Metab; 2020 Apr; 46(2):164-168. PubMed ID: 31816432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating impulsivity with probiotics in adults (PROBIA): study protocol of a multicenter, double-blind, randomized, placebo-controlled trial.
    Arteaga-Henríquez G; Rosales-Ortiz SK; Arias-Vásquez A; Bitter I; Ginsberg Y; Ibañez-Jimenez P; Kilencz T; Lavebratt C; Matura S; Reif A; Rethelyi J; Richarte V; Rommelse N; Siegl A; Ramos-Quiroga JA
    Trials; 2020 Feb; 21(1):161. PubMed ID: 32046750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Natural Soluble Polysaccharides on the Type 2 Diabetes through Modulating Gut Microbiota: A Review.
    Yang L; Li L; Wu X; Cai W; Lin Q; Zhu D; Liu H
    Curr Med Chem; 2021; 28(26):5368-5385. PubMed ID: 33687877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.
    Tripathy D; Daniele G; Fiorentino TV; Perez-Cadena Z; Chavez-Velasquez A; Kamath S; Fanti P; Jenkinson C; Andreozzi F; Federici M; Gastaldelli A; Defronzo RA; Folli F
    Diabetologia; 2013 Oct; 56(10):2153-63. PubMed ID: 23811853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study.
    Wu H; Tremaroli V; Schmidt C; Lundqvist A; Olsson LM; Krämer M; Gummesson A; Perkins R; Bergström G; Bäckhed F
    Cell Metab; 2020 Sep; 32(3):379-390.e3. PubMed ID: 32652044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.
    Pedersen C; Gallagher E; Horton F; Ellis RJ; Ijaz UZ; Wu H; Jaiyeola E; Diribe O; Duparc T; Cani PD; Gibson GR; Hinton P; Wright J; La Ragione R; Robertson MD
    Br J Nutr; 2016 Dec; 116(11):1869-1877. PubMed ID: 27974055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.
    Karamali M; Bahramimoghadam S; Sharifzadeh F; Asemi Z
    Appl Physiol Nutr Metab; 2018 Jun; 43(6):565-570. PubMed ID: 29316405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
    Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents.
    Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
    BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial.
    Feig DS; Murphy K; Asztalos E; Tomlinson G; Sanchez J; Zinman B; Ohlsson A; Ryan EA; Fantus IG; Armson AB; Lipscombe LL; Barrett JF;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):173. PubMed ID: 27435163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials.
    Tang H; Zhang X; Zhang J; Li Y; Del Gobbo LC; Zhai S; Song Y
    Diabetologia; 2016 Dec; 59(12):2546-2551. PubMed ID: 27628105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 40. Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes.
    Piuri G; Zocchi M; Della Porta M; Ficara V; Manoni M; Zuccotti GV; Pinotti L; Maier JA; Cazzola R
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33499378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.